Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any autosomal recessive non-syndromic intellectual disability in which the cause of the disease is a mutation in the TECR gene.
Features include always present findings: Delayed speech and language development and Intellectual disability; and common findings: Narrow palate and Intention tremor.
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:55 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 3 | Delayed speech and language development, Intention tremor, Intellectual disability |
Head and neck | 1 | Narrow palate |
TECR function has not been fully characterized.
Intellectual disability, autosomal recessive 14 is associated with mutations in the TECR gene on chromosome 19.
Genetic testing for TECR is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for intellectual disability, autosomal recessive 14 has been reported in the published literature.
Phenotype severity distribution: 2 always present features, 2 common features.
No clinical trials have been registered for intellectual disability, autosomal recessive 14.
35 publications have been identified in PubMed for intellectual disability, autosomal recessive 14. Research spans Review / Meta-Analysis (29%), Case Report / Case Series (23%), and Basic Science / Preclinical (23%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 10 | 29% |
Patient case studies | 8 | 23% |
Laboratory research | 8 | 23% |
Disease patterns and progression | 4 | 11% |
Other research | 2 | 6% |
Testing and diagnosis research | 2 | 6% |
New treatment approaches | 1 | 3% |
Jones SK (2026). [PMID: 42146557](https://pubmed.ncbi.nlm.nih.gov/42146557/). *bioRxiv*. [Basic Science / Preclinical]
Kido J (2026). [PMID: 42150437](https://pubmed.ncbi.nlm.nih.gov/42150437/). *Mol Genet Metab*. [Case Report / Case Series]
Dudic A (2026). [PMID: 40824224](https://pubmed.ncbi.nlm.nih.gov/40824224/). *J Pediatr Orthop*. [Other]
Muhammad A (2026). [PMID: 42046183](https://pubmed.ncbi.nlm.nih.gov/42046183/). *Mol Genet Genomic Med*. [Review / Meta-Analysis]
Pan X (2026). [PMID: 41764152](https://pubmed.ncbi.nlm.nih.gov/41764152/). *J Mol Med (Berl)*. [Basic Science / Preclinical]
Ek M (2026). [PMID: 41514368](https://pubmed.ncbi.nlm.nih.gov/41514368/). *Genome Med*. [Diagnostic / Biomarker]
Alimoradi E (2026). [PMID: 41656075](https://pubmed.ncbi.nlm.nih.gov/41656075/). *Mol Genet Genomic Med*. [Case Report / Case Series]
Salmaninejad A (2026). [PMID: 41866703](https://pubmed.ncbi.nlm.nih.gov/41866703/). *Mol Genet Genomic Med*. [Review / Meta-Analysis]
Shakeri S (2026). [PMID: 41724667](https://pubmed.ncbi.nlm.nih.gov/41724667/). *Mol Genet Genomic Med*. [Case Report / Case Series]
Hashem S (2025). [PMID: 41465175](https://pubmed.ncbi.nlm.nih.gov/41465175/). *Genes (Basel)*. [Review / Meta-Analysis]